Loading clinical trials...
Loading clinical trials...
Colon cancer and primary liver cancer are common malignant tumors with low survival rate worldwide, and unresectable primary liver cancer and colon cancer liver metastases have worse prognosis. End-st...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
RenJi Hospital
Collaborators
NCT07315204 · Liver Transplant Disorder
NCT06455280 · Autoimmune Liver Disease, Liver Transplant Disorder, and more
NCT06492408 · Hepatic Cancer, Surgery
NCT05001009 · Seriously Ill Patients, Cancer, and more
NCT07442214 · End-stage Liver Disease (ESLD), Liver Transplantation, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions